Evidence map›Paper›PMID 8526746›Full record

ArticleArchives of toxicology1995

Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts.

T C Lee, I C Ho

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Arsenome, Arsenobolome, and Arsenobiolome.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Impairment of antioxidant defenses as a contributor to arsenite-induced cell transformation.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2012
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

T C LeeInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.
I C Ho

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many studies have shown that oxygen radicals can be produced during arsenic metabolism. We report here that in human fibroblasts (HFW cells) sodium arsenite exposure caused increased formation of fluorescent dichlorofluorescein (DCF) by oxidation of the nonfluorescent form. The enhanced DCF fluorescence was inhibited by a radical scavenger, butylated hydroxytoluene. The effects of sodium arsenite treatment on cellular antioxidant activities were then examined. Treatment of HFW cells with sodium arsenite resulted in a significant increase in heme oxygenase activity and ferritin level. Sodium arsenite-enhanced heme oxygenase synthesis was inhibited by co-treatment of cells with the antioxidants sodium azide and dimethyl sulfoxide. Furthermore, sodium arsenite treatment did not apparently affect glucose-6-phosphate dehydrogenase activity, but resulted in significantly increased glutathione levels and superoxide dismutase activity, slightly decreased glutathione peroxidase activity, and significantly decreased catalase activity. Sodium arsenite toxicity was partly reduced by addition of catalase to the culture medium. These results imply that arsenite can enhance oxidative stress in HFW cells.

Indexed as

ArsenitesAzidesCatalaseCell LineCell SurvivalCulture MediaDimethyl SulfoxideElectrophoresis, Polyacrylamide GelFerritinsFibroblastsFluoresceinsGlucosephosphate DehydrogenaseGlutathioneGlutathione PeroxidaseHeme Oxygenase (Decyclizing)HumansArsenitesAzidesCatalaseCulture MediadiacetyldichlorofluoresceinDimethyl SulfoxideFerritinsFluoresceinsGlucosephosphate DehydrogenaseGlutathioneGlutathione PeroxidaseHeme Oxygenase (Decyclizing)Mutagenssodium arseniteSodium AzideSodium CompoundsSulfhydryl ReagentsSuperoxide Dismutase

Identifiers

PMID8526746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.